No it is not
IgG therapy is thought to help CIDP (chronic inflammatory demyelinating polyneuropathy) by reducing inflammation in the peripheral nerves and modifying the immune response. It can help to stabilize the condition and improve nerve function in some patients with CIDP.
communicable disease
Non-communicable. It is a neurological disease
non-communicable is the opposite of communicable.
non-communicable
Yes, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is classified as an autoimmune disease. In CIDP, the immune system mistakenly attacks the peripheral nerves, leading to inflammation and damage to the myelin sheath that insulates these nerves. This results in symptoms such as weakness, numbness, and impaired motor function. Treatment often involves therapies aimed at modulating the immune response.
Chronic inflammatory demyelinating polyneuropathy (CIDP) can affect individuals of any age, but it's more commonly diagnosed in adults, with a peak incidence between 40-60 years old. Both men and women are affected, although CIDP is slightly more prevalent in men. There is no specific racial or ethnic predilection for CIDP.
non-communicable
Non-communicable.
Leukemia is non communicable.
non communicable
Diphtheria is communicable.